OA3-5 LB Effect of vorinostat, hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating ART during acute HIV infection
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-07-01
|
Series: | Journal of Virus Eradication |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2055664020310177 |
_version_ | 1818595177494740992 |
---|---|
author | E. Kroon J. Ananworanich K. Eubanks J. Intasan S. Pinyakorn N. Chomont S.R. Lewin S. Palmer L. Trautmann H. Yang N. Chomchey N. Phanuphak K. Cooper P. Phanuphak M. Souza, de |
author_facet | E. Kroon J. Ananworanich K. Eubanks J. Intasan S. Pinyakorn N. Chomont S.R. Lewin S. Palmer L. Trautmann H. Yang N. Chomchey N. Phanuphak K. Cooper P. Phanuphak M. Souza, de |
author_sort | E. Kroon |
collection | DOAJ |
first_indexed | 2024-12-16T11:11:52Z |
format | Article |
id | doaj.art-6192abadda364ceda61926dd61fbb6b7 |
institution | Directory Open Access Journal |
issn | 2055-6640 |
language | English |
last_indexed | 2024-12-16T11:11:52Z |
publishDate | 2016-07-01 |
publisher | Elsevier |
record_format | Article |
series | Journal of Virus Eradication |
spelling | doaj.art-6192abadda364ceda61926dd61fbb6b72022-12-21T22:33:42ZengElsevierJournal of Virus Eradication2055-66402016-07-01256OA3-5 LB Effect of vorinostat, hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating ART during acute HIV infectionE. Kroon0J. Ananworanich1K. Eubanks2J. Intasan3S. Pinyakorn4N. Chomont5S.R. Lewin6S. Palmer7L. Trautmann8H. Yang9N. Chomchey10N. Phanuphak11K. Cooper12P. Phanuphak13M. Souza, de14Thai Red Cross AIDS Research Centre, SEARCH, Bangkok, ThailandThai Red Cross AIDS Research Centre, SEARCH, Bangkok, Thailand; Walter Reed Army Institute of Research, U.S. Military HIV Research Program, Bethesda, United States; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, United StatesCooper Human Systems, Cambridge, United StatesThai Red Cross AIDS Research Centre, SEARCH, Bangkok, ThailandWalter Reed Army Institute of Research, U.S. Military HIV Research Program, Bethesda, United States; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, United StatesUniversite de Montreal, CRCHUM and Department of Microbiology, Infectiology and Immunology, Montreal, CanadaUniversity of Melbourne, The Peter Doherty Institute for Infection, Melbourne, Australia; The Royal Melbourne Hospital, Melbourne, AustraliaThe University of Sydney, Sydney, Australia; The Westmead Institute for Medical Research, Sydney, AustraliaWalter Reed Army Institute of Research, U.S. Military HIV Research Program, Bethesda, United States; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, United StatesCooper Human Systems, Cambridge, United StatesThai Red Cross AIDS Research Centre, SEARCH, Bangkok, ThailandThai Red Cross AIDS Research Centre, SEARCH, Bangkok, ThailandCooper Human Systems, Cambridge, United StatesThai Red Cross AIDS Research Centre, SEARCH, Bangkok, Thailand; Thai Red Cross AIDS Research Centre, HIV-NAT, Bangkok, ThailandCooper Human Systems, Cambridge, United States; Thai Red Cross AIDS Research Centre, HIV-NAT, Bangkok, Thailandhttp://www.sciencedirect.com/science/article/pii/S2055664020310177 |
spellingShingle | E. Kroon J. Ananworanich K. Eubanks J. Intasan S. Pinyakorn N. Chomont S.R. Lewin S. Palmer L. Trautmann H. Yang N. Chomchey N. Phanuphak K. Cooper P. Phanuphak M. Souza, de OA3-5 LB Effect of vorinostat, hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating ART during acute HIV infection Journal of Virus Eradication |
title | OA3-5 LB Effect of vorinostat, hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating ART during acute HIV infection |
title_full | OA3-5 LB Effect of vorinostat, hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating ART during acute HIV infection |
title_fullStr | OA3-5 LB Effect of vorinostat, hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating ART during acute HIV infection |
title_full_unstemmed | OA3-5 LB Effect of vorinostat, hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating ART during acute HIV infection |
title_short | OA3-5 LB Effect of vorinostat, hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating ART during acute HIV infection |
title_sort | oa3 5 lb effect of vorinostat hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating art during acute hiv infection |
url | http://www.sciencedirect.com/science/article/pii/S2055664020310177 |
work_keys_str_mv | AT ekroon oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection AT jananworanich oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection AT keubanks oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection AT jintasan oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection AT spinyakorn oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection AT nchomont oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection AT srlewin oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection AT spalmer oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection AT ltrautmann oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection AT hyang oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection AT nchomchey oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection AT nphanuphak oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection AT kcooper oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection AT pphanuphak oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection AT msouzade oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection |